5MHD

Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutions.


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: 20 structures for lowest energy 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structure and pharmaceutical formulation development of a new long-acting recombinant human insulin analog studied by NMR and MS.

Bednarek, E.Sitkowski, J.Bocian, W.Borowicz, P.Pucienniczak, G.Stadnik, D.Surmacz-Chwedoruk, W.Jaworska, B.Kozerski, L.

(2017) J Pharm Biomed Anal 135: 126-132

  • DOI: 10.1016/j.jpba.2016.12.005
  • Primary Citation of Related Structures:  
    5MHD

  • PubMed Abstract: 
  • A monomer structure of a novel human insulin analog A22 S -B3 K -B31 R (SK3R) has been characterized by NMR in water/acetonitrile solution and compared with the structure of human insulin (HIS) established in the same me ...

    A monomer structure of a novel human insulin analog A22 S -B3 K -B31 R (SK3R) has been characterized by NMR in water/acetonitrile solution and compared with the structure of human insulin (HIS) established in the same medium. The composition of the oligomer ensemble for neat insulins in water was qualitatively assessed by monitoring, derived from NMR experiment, translational diffusion coefficient Dix10 -10 m 2 s -1 , whose value is a population averaged of individual coefficients for species in oligomeric ensemble. Nanospray ESI/MS experiment was used to establish the masses of oligomers in pharmaceutical formulation of the SK3R insulin. The pharmacodynamic data were established and compared to insulin glargine characterized by the same profile of action in diabetics. The oligomerization process of insulin during development of pharmaceutical formulation with routinely used excipients has been studied using translation diffusion coefficient Dix10 -10 m 2 s -1 established in water solution. These properties were compared with those of human insulin (HIS) which is a standard reference for novel recombinant insulins.


    Organizational Affiliation

    National Medicines Institute, 00-725 Warsaw, Poland. Electronic address: l.kozerski@nil.gov.pl.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Insulin A22Homo sapiensMutation(s): 0 
Gene Names: INS
Find proteins for P01308 (Homo sapiens)
Explore P01308 
Go to UniProtKB:  P01308
NIH Common Fund Data Resources
PHAROS:  P01308
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
Insulin B31Homo sapiensMutation(s): 0 
Gene Names: INS
Find proteins for P01308 (Homo sapiens)
Explore P01308 
Go to UniProtKB:  P01308
NIH Common Fund Data Resources
PHAROS:  P01308
Protein Feature View
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: 20 structures for lowest energy 
  • OLDERADO: 5MHD Olderado

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
NCBiRPolandPBS2/A27/9/2013

Revision History 

  • Version 1.0: 2017-08-09
    Type: Initial release
  • Version 1.1: 2019-05-08
    Changes: Data collection